StockData
Maze Therapeutics, Inc. logo

Maze Therapeutics, Inc. (MAZE) stock

MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$32.43+1.23 (+3.94%)

Close on Nov 19, 2026Market cap $1.80BP/E –Yield –

Maze Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Maze Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $167.50M. For fiscal 2024 it was $167.50M.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$167.50M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$20.00M-87.9%
Q2 FY2025Jun 30, 2025$0–
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$2.50M–
Q2 FY2024Jun 30, 2024$165.00M–

More Maze Therapeutics figures

See a number that looks wrong?